ICOS and graft versus host disease: Previous studies have shown that ICOS−/− T cells have reduced IFN-γ yet elevated IL-4, which resulted in alleviated acute GVHD (aGVHD) (30); blocking ICOS confirmed this reduced GVHD severity (31).